<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">zdor</journal-id><journal-title-group><journal-title xml:lang="ru">Проблемы здоровья и экологии</journal-title><trans-title-group xml:lang="en"><trans-title>Health and Ecology Issues</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2220-0967</issn><issn pub-type="epub">2708-6011</issn><publisher><publisher-name>Gomel State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.51523/2708-6011.2010-7-4-3</article-id><article-id custom-type="elpub" pub-id-type="custom">zdor-1000</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Без раздела</subject></subj-group></article-categories><title-group><article-title>ОСТРЫЙ КОРОНАРНЫЙ СИНДРОМ: СОВРЕМЕННЫЕ ВОЗМОЖНОСТИ ТЕРАПИИ (обзор литературы, часть III)</article-title><trans-title-group xml:lang="en"><trans-title>THE ACUTE CORONARY SYNDROME: POSSIBILITY UP-TO-DATE THERAPY (literature review. Part III)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Саливончик</surname><given-names>Д. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Salivonchik</surname><given-names>D. P.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Гомельский областной клинический кардиологический диспансер</institution></aff><aff xml:lang="en"><institution>Gomel Regional Clinical Cardial Dinspensary</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2010</year></pub-date><pub-date pub-type="epub"><day>28</day><month>12</month><year>2010</year></pub-date><volume>0</volume><issue>4</issue><fpage>19</fpage><lpage>25</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Саливончик Д.П., 2010</copyright-statement><copyright-year>2010</copyright-year><copyright-holder xml:lang="ru">Саливончик Д.П.</copyright-holder><copyright-holder xml:lang="en">Salivonchik D.P.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.gsmu.by/jour/article/view/1000">https://journal.gsmu.by/jour/article/view/1000</self-uri><abstract><p>В обзоре представлена информация о современной медикаментозной и инструментальной терапии острого коронарного синдрома (ОКС).</p></abstract><trans-abstract xml:lang="en"><p>The information about the modern medical treatment of the acute coronary syndrome was presented in the this review.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>острый коронарный синдром</kwd><kwd>инфаркт миокарда</kwd><kwd>нестабильная стенокардия</kwd><kwd>acute coronary syndrome</kwd><kwd>myocardial infarction</kwd><kwd>unstable angina</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Беленков, Ю. Н. Функциональная диагностика сердечно-сосудистых заболеваний / Ю. Н. Беленков, С. К. Терновой. - М.: «Геотар-Медиа», 2007. - 976 с.</mixed-citation><mixed-citation xml:lang="en">Беленков, Ю. Н. Функциональная диагностика сердечно-сосудистых заболеваний / Ю. Н. Беленков, С. К. Терновой. - М.: «Геотар-Медиа», 2007. - 976 с.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Берштейн, Л. Л. Оценка эффективности реперфузии при остром инфаркте миокарда: современные концепции и методы / Л. Л. Берштейн, В. И. Новиков, Ю. Н. Гришкин // Рос. кардиол. журн. - 2005. - № 1 (51). - С. 73-79.</mixed-citation><mixed-citation xml:lang="en">Берштейн, Л. Л. Оценка эффективности реперфузии при остром инфаркте миокарда: современные концепции и методы / Л. Л. Берштейн, В. И. Новиков, Ю. Н. Гришкин // Рос. кардиол. журн. - 2005. - № 1 (51). - С. 73-79.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Влияние отсроченной коронарной ангиопластики после тромболитической терапии на исход острого инфаркта миокарда / С. А. Заволожин [и др.] // Кардиология. - 2006. - Т. 46, № 10. - С. 8-13.</mixed-citation><mixed-citation xml:lang="en">Влияние отсроченной коронарной ангиопластики после тромболитической терапии на исход острого инфаркта миокарда / С. А. Заволожин [и др.] // Кардиология. - 2006. - Т. 46, № 10. - С. 8-13.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Инфаркт миокарда; диагностика и лечение: пособие для врачей / Л. З. Полонецкий [и др.]; под ред. Л. З. Полонецкого. - Минск: Доктор Дизайн, 2005. - 112 с.</mixed-citation><mixed-citation xml:lang="en">Инфаркт миокарда; диагностика и лечение: пособие для врачей / Л. З. Полонецкий [и др.]; под ред. Л. З. Полонецкого. - Минск: Доктор Дизайн, 2005. - 112 с.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Пархоменко, А. Н. Жизнеспособный миокард и кардиопротекция: возможности метаболической терапии при острой и хронической формах ишемической болезни сердца / А. Н. Пархоменко // Украинский медицинский журнал. - 2001. - № 3 (23). - С. 5-11.</mixed-citation><mixed-citation xml:lang="en">Пархоменко, А. Н. Жизнеспособный миокард и кардиопротекция: возможности метаболической терапии при острой и хронической формах ишемической болезни сердца / А. Н. Пархоменко // Украинский медицинский журнал. - 2001. - № 3 (23). - С. 5-11.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Шпектор, А. В. Реперфузионная терапия острого инфаркта миокарда / А. В. Шпектор, Е. Ю. Васильева // Бюл. НЦССХ им. А. Н. Бакулева РАМН. - 2004. - С. 38-46.</mixed-citation><mixed-citation xml:lang="en">Шпектор, А. В. Реперфузионная терапия острого инфаркта миокарда / А. В. Шпектор, Е. Ю. Васильева // Бюл. НЦССХ им. А. Н. Бакулева РАМН. - 2004. - С. 38-46.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-Elevation myocardial infarction Therapy) study / P. W. Armstrong and WEST steering Committee // Eur. Heart J. - 2006.</mixed-citation><mixed-citation xml:lang="en">A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-Elevation myocardial infarction Therapy) study / P. W. Armstrong and WEST steering Committee // Eur. Heart J. - 2006.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">A score predict failure of reperfusion after fibrinolytic therapy for acute myocardial infarction / J. K. French [et al.] // Lancet. - 2003. - Vol. 145(3). - P. 508-514.</mixed-citation><mixed-citation xml:lang="en">A score predict failure of reperfusion after fibrinolytic therapy for acute myocardial infarction / J. K. French [et al.] // Lancet. - 2003. - Vol. 145(3). - P. 508-514.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Aborted myocardial infarction in patients with ST-elevation: insight from the ASSENT-3 ECG substudy / T. Taher [et al.] // J. Am. Coll. Cardiol. - 2004. - Vol. 44. - P. 38-43.</mixed-citation><mixed-citation xml:lang="en">Aborted myocardial infarction in patients with ST-elevation: insight from the ASSENT-3 ECG substudy / T. Taher [et al.] // J. Am. Coll. Cardiol. - 2004. - Vol. 44. - P. 38-43.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Activated partial thromboplastin time and outcome after thrombolytiс therapy for acute myocardial infarction: result from the GUSTO-I trial / C. B. Granger [et al.] // Circulation. - 1996. - Vol. 93. - P. 870-878.</mixed-citation><mixed-citation xml:lang="en">Activated partial thromboplastin time and outcome after thrombolytiс therapy for acute myocardial infarction: result from the GUSTO-I trial / C. B. Granger [et al.] // Circulation. - 1996. - Vol. 93. - P. 870-878.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Bhatia, L. Clinical implication of ST-segment non-resolution after thrombolysis for myocardial infarction / L. Bhatia, G. J. Clesham, D. R. Turner // J. R. Sjc. Med. - 2004. - Vol. 97(12). - P. 566-570.</mixed-citation><mixed-citation xml:lang="en">Bhatia, L. Clinical implication of ST-segment non-resolution after thrombolysis for myocardial infarction / L. Bhatia, G. J. Clesham, D. R. Turner // J. R. Sjc. Med. - 2004. - Vol. 97(12). - P. 566-570.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Coronary angiographic finding after non-Q wave myocardial infarction: an analysis from the VANOWISH trial (abstr.) / W. E. Boden [et al.] // Eur. Heart J. - 1997. - Vol. 18. - 123 p.</mixed-citation><mixed-citation xml:lang="en">Coronary angiographic finding after non-Q wave myocardial infarction: an analysis from the VANOWISH trial (abstr.) / W. E. Boden [et al.] // Eur. Heart J. - 1997. - Vol. 18. - 123 p.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Coronary intervention for persistent occlusion after myocardial infarction / J. S. Hochman [et al.] // N. Engl. J. Med. - 2006. - Vol. 355. - P. 2395-2407.</mixed-citation><mixed-citation xml:lang="en">Coronary intervention for persistent occlusion after myocardial infarction / J. S. Hochman [et al.] // N. Engl. J. Med. - 2006. - Vol. 355. - P. 2395-2407.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI) DANish trial in ACUTE Myocardial Infarction / J. K. Madsen [et al.] // Circulation. - 1997. - Vol. 96. - P. 748-755.</mixed-citation><mixed-citation xml:lang="en">Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI) DANish trial in ACUTE Myocardial Infarction / J. K. Madsen [et al.] // Circulation. - 1997. - Vol. 96. - P. 748-755.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications / T. F. Luscher [et al.] // Circulation. - 2007. - Vol. 115. - P. 1051-1058.</mixed-citation><mixed-citation xml:lang="en">Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications / T. F. Luscher [et al.] // Circulation. - 2007. - Vol. 115. - P. 1051-1058.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour / E. Boersma [et al.] // Lancet. - 1996. - Vol. 348. - P. 771-775.</mixed-citation><mixed-citation xml:lang="en">Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour / E. Boersma [et al.] // Lancet. - 1996. - Vol. 348. - P. 771-775.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Five-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome - the British Heart Foundation RITA 3 randomized trial / K. A. Fox [et al.] // Lancet. - 2005. - Vol. 366. - P. 914-920.</mixed-citation><mixed-citation xml:lang="en">Five-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome - the British Heart Foundation RITA 3 randomized trial / K. A. Fox [et al.] // Lancet. - 2005. - Vol. 366. - P. 914-920.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Grines, C. L. Should thrombolysis or primary angioplasty be the treatment of choice for acute myocardial infarction? Primary angioplasty - the strategy of choice / C. L. Grines // N. Engl. J. Med. - 1996. - Vol. 335. - P. 1313-1316.</mixed-citation><mixed-citation xml:lang="en">Grines, C. L. Should thrombolysis or primary angioplasty be the treatment of choice for acute myocardial infarction? Primary angioplasty - the strategy of choice / C. L. Grines // N. Engl. J. Med. - 1996. - Vol. 335. - P. 1313-1316.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Grunewald, M. Meta-analysis of all available published clinical trials (1958-1990) on thrombolytic therapy for AMI: Relative efficacy of different therapeutic strategies / M. Grunewald, E. Seifreid // Fibrinolysis. - 1994. - Vol. 8. - P. 67-86.</mixed-citation><mixed-citation xml:lang="en">Grunewald, M. Meta-analysis of all available published clinical trials (1958-1990) on thrombolytic therapy for AMI: Relative efficacy of different therapeutic strategies / M. Grunewald, E. Seifreid // Fibrinolysis. - 1994. - Vol. 8. - P. 67-86.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and morbidity results from all randomized trials of more than 1000 patients. Fibrinolytic Therapy Trialists´ (FIT) Collaborative Group // Lancet. - 1994. - Vol. 343. - P. 311-322.</mixed-citation><mixed-citation xml:lang="en">Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and morbidity results from all randomized trials of more than 1000 patients. Fibrinolytic Therapy Trialists´ (FIT) Collaborative Group // Lancet. - 1994. - Vol. 343. - P. 311-322.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Insulin resistance as a predictors for restenosis after coronary stenting / K. Nishioa [et al.] // International Journal of Cardiology. - 2005. - Vol. 103. - P. 128-134.</mixed-citation><mixed-citation xml:lang="en">Insulin resistance as a predictors for restenosis after coronary stenting / K. Nishioa [et al.] // International Journal of Cardiology. - 2005. - Vol. 103. - P. 128-134.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina / Non ST-Elevation Myocardial Infarction: Executive Summary / L. Jeffrey [et al.] // Circulation. - 2007. - Vol. 116. - P. 803-877.</mixed-citation><mixed-citation xml:lang="en">ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina / Non ST-Elevation Myocardial Infarction: Executive Summary / L. Jeffrey [et al.] // Circulation. - 2007. - Vol. 116. - P. 803-877.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Keely, E. C. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials / E. C. Keely, J. A. Boura, C. L. Grines // Lancet. - 2003. - Vol. 361. - P. 120-130.</mixed-citation><mixed-citation xml:lang="en">Keely, E. C. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials / E. C. Keely, J. A. Boura, C. L. Grines // Lancet. - 2003. - Vol. 361. - P. 120-130.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials / A. A. Bavry [et al.] // Am. J. Med. - 2006. - Vol. 119. - P. 1056-1061.</mixed-citation><mixed-citation xml:lang="en">Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials / A. A. Bavry [et al.] // Am. J. Med. - 2006. - Vol. 119. - P. 1056-1061.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Long distance transport for primary angioplasty vs. immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial - PRAGUE-2 / P. Widimsky [et al.] // Eur. Heart J. - 2003. - Vol. 24. - P. 94-104.</mixed-citation><mixed-citation xml:lang="en">Long distance transport for primary angioplasty vs. immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial - PRAGUE-2 / P. Widimsky [et al.] // Eur. Heart J. - 2003. - Vol. 24. - P. 94-104.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Mortality and prehospital thrombolysis for acute myocardial infarction: a meta-analysis / L. J. Morrison [et al.] // J.A.M.A. - 2000. - Vol. 283. - P. 2686-2692.</mixed-citation><mixed-citation xml:lang="en">Mortality and prehospital thrombolysis for acute myocardial infarction: a meta-analysis / L. J. Morrison [et al.] // J.A.M.A. - 2000. - Vol. 283. - P. 2686-2692.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 investigators. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomized trial in acute myocardial infarction / Lancet. - 2001. - Vol. 358. - P. 605-613.</mixed-citation><mixed-citation xml:lang="en">The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 investigators. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomized trial in acute myocardial infarction / Lancet. - 2001. - Vol. 358. - P. 605-613.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">The GISSI Investigators Ten-year follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction: result of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarcto-1 study / M. G. Franzosi [et al.] // Circulation. - 1998. - Vol. 98. - P. 2659-2665.</mixed-citation><mixed-citation xml:lang="en">The GISSI Investigators Ten-year follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction: result of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarcto-1 study / M. G. Franzosi [et al.] // Circulation. - 1998. - Vol. 98. - P. 2659-2665.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">The ISIS-2 Collaborative Group ISIS-2: 10 years survival among patients with suspected acute myocardial infarction in randomized comparison of intravenous streptokinase, oral aspirin, both, or neither / C. Baigent [et al.] // B.M.J. - 1998. - Vol. 316. - P. 1337-1343.</mixed-citation><mixed-citation xml:lang="en">The ISIS-2 Collaborative Group ISIS-2: 10 years survival among patients with suspected acute myocardial infarction in randomized comparison of intravenous streptokinase, oral aspirin, both, or neither / C. Baigent [et al.] // B.M.J. - 1998. - Vol. 316. - P. 1337-1343.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Verheugt, F.W.A. Aborted myocardial infarction: a new target for reperfusion therapy / F.W.A. Verheugt, B. J. Gersh, P. W. Armstrong // Eur. Heart J. - 2006. - Vol. 27. - P. 901-904.</mixed-citation><mixed-citation xml:lang="en">Verheugt, F.W.A. Aborted myocardial infarction: a new target for reperfusion therapy / F.W.A. Verheugt, B. J. Gersh, P. W. Armstrong // Eur. Heart J. - 2006. - Vol. 27. - P. 901-904.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
